One assumption is that EGFR mutation is an early and clonal event in tumor evolution,45 and tumor harboring EGFR mutations seemed to act in line with “attenuated progression”, described as initial oligometastases and gradually gaining metastatic capacity over time.46 The gene discussed is EGFR; the disease is neoplasm.